alexa Patient with Compound Heterozygosity

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

cardiology and cardiovascular medicine

London, UK

World Clinical Cancer Research and Diagnosis

Vancouver, Canada

Global Summit on Oncology and Cancer Therapy

New York, USA
Patient with Compound Heterozygosity

IVS-1 25bp deletion in the β-globin gene is rare entity in South East Asia region. We report the first case of β- thalassaemia major in a Malay girl from Malaysia with IVS-1 25bp deletion heterozygously compounded with IVS 1-5 (G>C) consensus mutation.


Citation: Hamid FSA, Ahmad R, Aziz NA, Omar SL, Arif SHHM, et al. (2015) β-Thalassaemia Major Malay Patient with Compound Heterozygosity for IVS 1-5 (G>C) Mutation and IVS-1 25bp Deletion: Case Report. J Blood Disorders Transf 6:260. doi: 10.4172/2155-9864.1000260

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger